VAERS reports by lot

GSK Hepatitis A lot 7NX57: VAERS reports

36 VAERS reports list lot 7NX57 as a GSK Hepatitis A vaccine, received between 2025-03-04 and 2026-03-16. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
36
Reports
6%
Marked serious
1
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)650%
Cardiac / Cardiovascular217%
Autoimmune / Immune-mediated217%
Neurological18%
Gastrointestinal18%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
New York5
Arizona4
California3
Massachusetts3
Michigan3
Kansas2
Pennsylvania2
New Jersey2
Nebraska1
Tennessee1
Louisiana1
Oregon1

Reports by month received

MonthReportsBar
2025-032
2025-045
2025-051
2025-078
2025-083
2025-091
2025-103
2025-114
2025-124
2026-011
2026-022
2026-032

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK Hepatitis A lots (A–Z): 772YT · 77X47 · 7HJ74 · 7YA99 · 9255P · 92DJ3

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.